EU fines Teva for blocking cheaper generic drugs - Israel News, Ynetnews
 
ynetnews
web


   Israel News

Israel News
World News
Israel Opinion
Jewish
Israel Business
Israel Culture
Israel Travel
Breaking News

 

EU fines Teva for blocking cheaper generic drugs

Reuters
Published: 07.09.14, 15:38 / Israel News

European Union antitrust regulators fined French drugmaker Servier, Israel's Teva and four others a total of 428 million euros ($583 million) on Wednesday for blocking cheaper generic medicine.

 

The sanctions are the third by the European Commission against so-called pay-for-delay deals in the pharmaceutical industry, where brand-name drugmakers pay cheaper non-brand generics firms to hold back from launching rival medicines.

 

"Servier had a strategy to systematically buy out any competitive threats to make sure that they stayed out of the market. Such behaviour is clearly anti-competitive and abusive," European Competition Commissioner Joaquin Almunia said in a statement.

 

  PrintPrint  Send to friendSend to friend   
Tag with Del.icio.us Bookmark to del.icio.us




 

RSS RSS | About | Contact Us | Privacy Policy | Terms of use | Advertise with us | Site Map

Site developed by  YIT Advanced Technology Solutions

 
פיקוד העורף התרעה במרחב:
    רשימת יישובים במרחב